EFFICACY AND SAFETY OF ETOPOSIDE IN COMBINATION WITH G-CSF, LOW-DOSE CYTARABINE AND ACLARUBICIN IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA

被引：0

作者：

Gao, L. ^{[1
]}

Feng, Y. M. ^{[1
]}

Yan, H. J. ^{[1
]}

Zhang, Y. Q. ^{[2
]}

Zhang, C.

Gao, L. ^{[1
]}

Kong, P. Y. ^{[1
]}

Liu, Y. ^{[1
]}

Zhu, L. D. ^{[3
]}

Zeng, Y. J. ^{[1
]}

Rao, J. ^{[1
]}

Su, Y. ^{[4
]}

Yang, T. H. ^{[5
]}

Wang, S. B. ^{[6
]}

Li, H. M. ^{[7
]}

Lou, S. F. ^{[8
]}

Zhang, X. ^{[1
]}

机构：

[1] Third Mil Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing, Peoples R China

[2] Third Mil Med Univ, Collage Mil Prevent Med, Dept Hlth Stat, Chongqing, Peoples R China

[3] Third Mil Med Univ, Collage Mil Prevent Med, Dept Hematol, Chongqing, Peoples R China

[4] Chengdu Mil Reg PLA, Gen Hosp, Dept Hematol, Chengdu, Sichuan, Peoples R China

[5] Yunnan Prov Peoples Hosp, Dept Hematol, Kunming, Yunnan, Peoples R China

[6] Kunming Mil Reg PLA, Gen Hosp, Dept Hematol, Kunming, Yunnan, Peoples R China

[7] Yunnan Med Coll, Dept Hematol, Kunming, Peoples R China

[8] Chongqing Med Univ, Affiliated Hosp 2, Dept Hematol, Chongqing, Peoples R China

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

LB2245

引用

页码：387 / 387

页数：1

共 50 条

[1] Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia
Li, Jianyong
Chen, Yaoyu
Zhu, Yu
Zhou, Jianfeng
Xu, Yanli
Li, Yan
Yu, Kang
Pan, Ling
Wang, Jianmin
Ding, Jiahua
Gu, Jian
Zhou, Shanhua
Shi, Jinning
Hong, Ming
Xu, Ji
Pan, Liangqin
Duan, Limin
Zhang, Run
Zhang, Sujiang
Zhu, Huayuan
Lu, Hua
Liu, Peng
Qiu, Hongxia
Wu, Hanxin
Qian, Sixuan
ONCOTARGET, 2015, 6 (08) : 6448 - 6458
[2] Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia
Zhu, Jun-Feng
Dai, Hai-Ping
Zhang, Qian-Qian
Yin, Jia
Li, Zheng
Cui, Qin-Ya
Tian, Xiao-Peng
Liu, Si-Ning
Jin, Zheng-Ming
Zhu, Xia-Ming
Wu, De-Pei
Tang, Xiao-Wen
FRONTIERS IN ONCOLOGY, 2022, 12
[3] Efficacy and safety of G-CSF, low-dose cytarabine and aclarubicin in combination with L-asparaginase, prednisone in the treatment of refractory or relapsed acute lymphoblastic leukemia
Zhou, Keshu
Song, Yongping
Zhang, Yanli
Wei, Xudong
Fu, Yuewen
Yu, Fengkuan
Zhou, Hu
Liu, Xinjian
Zhou, Jian
Fang, Baijun
LEUKEMIA RESEARCH, 2017, 62 : 29 - 33
[4] Decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin is as effective as standard dose chemotherapy in the induction treatment for patients aged from 55 to 69 years old with newly diagnosed acute myeloid leukemia
Huang, Jiayu
Hong, Ming
Zhu, Yu
Zhao, Huihui
Zhang, Xiaoyan
Wu, Yujie
Lian, Yun
Zhao, Xiaoli
Li, Jianyong
Qian, Sixuan
LEUKEMIA & LYMPHOMA, 2018, 59 (11) : 2570 - 2579
[5] Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China
Zhang, Xi
Li, Yunlong
Zhang, Yanqi
Chen, Xinghua
Zhang, Cheng
Gao, Li
Kong, Peiyan
Liu, Yao
Wen, Qin
Zeng, Yunjing
Wang, Qingyu
Su, Yi
Wang, Chunsen
Wang, Sanbin
Yuan, Zhong
Gao, Lei
LEUKEMIA RESEARCH, 2013, 37 (06) : 657 - 664
[6] Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in MDS-EB and AML-MRC
Liu, Jing
Jia, Jinsong
Gong, Li-Zhong
Lu, Shen-ye
Zhu, Hong-Hu
Huang, Xiao-Jun
Jiang, Hao
BLOOD, 2017, 130
[7] Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Mitoxantrone in Pediatric Refractory and Relapse Acute Myeloid Leukemia and MDS-Raebt
Fan, Liyan
Chen, Aili
Hu, Yixin
Xiao, Peifang
Lu, Jun
Li, Jie
He, Hailong
Wang, Yi
Hu, Shaoyan
BLOOD, 2018, 132
[8] Venetoclax plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for elderly or unfit patients with newly diagnosed acute myeloid leukemia: a multicenter, prospective study
Ma, Hongbing
Du, Yiwen
Li, Jianjun
Rao, Jin
Guo, Yong
Yang, Yunfan
Zhang, Duanzhong
Wang, Jia
Liao, Yi
Gong, Yuping
ANNALS OF HEMATOLOGY, 2024, : 5315 - 5323
[9] Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia
Martinez-Cuadron, David
Montesinos, Pau
Oriol, Albert
Salamero, Olga
Vidriales, Belen
Bergua, Juan
Herrera, Pilar
Vives, Susanna
Sanz, Jaime
Carpio, Cecilia
Rodriguez-Veiga, Rebeca
Moscardo, Federico
Sanz, Miguel A.
ANNALS OF HEMATOLOGY, 2014, 93 (01) : 43 - 46
[10] Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia
David Martínez-Cuadrón
Pau Montesinos
Albert Oriol
Olga Salamero
Belén Vidriales
Juan Bergua
Pilar Herrera
Susanna Vives
Jaime Sanz
Cecilia Carpio
Rebeca Rodríguez-Veiga
Federico Moscardó
Miguel A. Sanz
Annals of Hematology, 2014, 93 : 43 - 46

← 1 2 3 4 5 →